• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

受体酪氨酸激酶EphB4及其配体ephrin-B2在乳腺形态发生过程中的细胞类型特异性和雌激素依赖性表达。

Cell-type specific and estrogen dependent expression of the receptor tyrosine kinase EphB4 and its ligand ephrin-B2 during mammary gland morphogenesis.

作者信息

Nikolova Z, Djonov V, Zuercher G, Andres A C, Ziemiecki A

机构信息

Department of Clinical Research, University of Berne, Tiefenaustrasse 120, CH-3004 Berne, Switzerland.

出版信息

J Cell Sci. 1998 Sep;111 ( Pt 18):2741-51. doi: 10.1242/jcs.111.18.2741.

DOI:10.1242/jcs.111.18.2741
PMID:9718367
Abstract

Morphogenesis of the mammary gland occurs mainly during adult life and is dependent on a complex interplay of hormonal, cell-cell and cell-matrix interactions. The molecular mechanisms involved in pattern formation of the mammary epithelium in adult life are poorly understood. Recently, several members of the Eph family of receptor tyrosine kinases and their ligands have been shown to participate in pattern formation during embryogenesis and conceivably may fulfill similar functions during adult morphogenesis. We have investigated the expression of a member of this family, EphB4, and its cognate ligand, ephrin-B2, during normal and malignant mouse mammary morphogenesis. A spatially, temporarily and hormonally coordinated expression of both the receptor and ligand was observed. The receptor was predominantly localized in the myoepithelial cells surrounding the ducts and alveoli whereas ligand expression was limited to the luminal epithelial cells. Expression of both was induced at the onset of gland morphogenesis at puberty and was differentially regulated during the estrus cycle. Ovariectomy of pre-pubertal or adult females abolished the expression of both receptor and ligand and administration of estrogen alone was sufficient to restore their normal expression. Disruption of the balanced expression was observed during experimental mouse mammary carcinogenesis. Ligand expression was lost at the onset of tumorigenesis and receptor expression shifted from myoepithelial to epithelial cells with progressive malignancy. These results implicate both the EphB4 receptor and its ligand ephrin-B2 in the hormone dependent morphogenesis of the mammary gland. Furthermore, their deregulated expression may contribute to mammary carcinogenesis.

摘要

乳腺的形态发生主要发生在成年期,并且依赖于激素、细胞 - 细胞以及细胞 - 基质相互作用之间复杂的相互影响。目前对于成年期乳腺上皮细胞模式形成所涉及的分子机制了解甚少。最近,受体酪氨酸激酶Eph家族的几个成员及其配体已被证明参与胚胎发育过程中的模式形成,并且可以想象在成年形态发生过程中可能发挥类似的功能。我们研究了该家族成员之一EphB4及其同源配体ephrin - B2在正常和恶性小鼠乳腺形态发生过程中的表达情况。观察到受体和配体在空间、时间和激素方面的协调表达。受体主要定位于导管和腺泡周围的肌上皮细胞,而配体表达仅限于管腔上皮细胞。两者的表达在青春期腺体形态发生开始时被诱导,并且在发情周期中受到差异调节。对青春期前或成年雌性小鼠进行卵巢切除会消除受体和配体的表达,单独给予雌激素足以恢复它们的正常表达。在实验性小鼠乳腺癌发生过程中观察到平衡表达的破坏。在肿瘤发生开始时配体表达丧失,并且随着恶性程度的进展,受体表达从肌上皮细胞转移到上皮细胞。这些结果表明EphB4受体及其配体ephrin - B2都参与乳腺的激素依赖性形态发生。此外,它们的表达失调可能导致乳腺癌的发生。

相似文献

1
Cell-type specific and estrogen dependent expression of the receptor tyrosine kinase EphB4 and its ligand ephrin-B2 during mammary gland morphogenesis.受体酪氨酸激酶EphB4及其配体ephrin-B2在乳腺形态发生过程中的细胞类型特异性和雌激素依赖性表达。
J Cell Sci. 1998 Sep;111 ( Pt 18):2741-51. doi: 10.1242/jcs.111.18.2741.
2
Deregulated ephrin-B2 expression in the mammary gland interferes with the development of both the glandular epithelium and vasculature and promotes metastasis formation.乳腺中 Ephrin-B2 表达失调会干扰腺上皮和脉管系统的发育,并促进转移灶形成。
Int J Oncol. 2009 Sep;35(3):525-36. doi: 10.3892/ijo_00000364.
3
Preponderance of cells with stem cell characteristics in metastasising mouse mammary tumours induced by deregulated EphB4 and ephrin-B2 expression.在 EphB4 和 ephrin-B2 表达失调诱导的转移性小鼠乳腺肿瘤中,具有干细胞特征的细胞占优势。
Int J Oncol. 2011 Jan;38(1):151-60.
4
Altered mammary epithelial development, pattern formation and involution in transgenic mice expressing the EphB4 receptor tyrosine kinase.表达EphB4受体酪氨酸激酶的转基因小鼠乳腺上皮发育、模式形成及退化的改变
J Cell Sci. 2002 Jan 1;115(Pt 1):25-37. doi: 10.1242/jcs.115.1.25.
5
Expression of receptor tyrosine kinase EphB4 and its ligand ephrin-B2 is associated with malignant potential in endometrial cancer.受体酪氨酸激酶EphB4及其配体ephrin - B2的表达与子宫内膜癌的恶性潜能相关。
Oncol Rep. 2001 May-Jun;8(3):567-73. doi: 10.3892/or.8.3.567.
6
Mammary epithelial-specific knockout of the ephrin-B2 gene leads to precocious epithelial cell death at lactation.乳腺上皮细胞特异性敲除 Ephrin-B2 基因导致哺乳期上皮细胞过早死亡。
Dev Growth Differ. 2009 Dec;51(9):809-19. doi: 10.1111/j.1440-169X.2009.01140.x. Epub 2009 Oct 15.
7
Deregulated ephrin-B2 signaling in mammary epithelial cells alters the stem cell compartment and interferes with the epithelial differentiation pathway.在乳腺上皮细胞中,去调控的 Ephrin-B2 信号改变了干细胞隔室并干扰了上皮细胞分化途径。
Int J Oncol. 2012 Feb;40(2):357-69. doi: 10.3892/ijo.2011.1238. Epub 2011 Oct 20.
8
Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development.受体EphB4及其特异性跨膜配体ephrin-B2在心血管发育中的对称突变表型。
Mol Cell. 1999 Sep;4(3):403-14. doi: 10.1016/s1097-2765(00)80342-1.
9
Comparative analysis of embryonic gene expression defines potential interaction sites for Xenopus EphB4 receptors with ephrin-B ligands.胚胎基因表达的比较分析确定了非洲爪蟾EphB4受体与ephrin - B配体的潜在相互作用位点。
Dev Dyn. 1999 Dec;216(4-5):361-73. doi: 10.1002/(SICI)1097-0177(199912)216:4/5<361::AID-DVDY5>3.0.CO;2-W.
10
The receptor tyrosine kinase EphB4 and ephrin-B ligands restrict angiogenic growth of embryonic veins in Xenopus laevis.受体酪氨酸激酶EphB4和ephrin-B配体限制非洲爪蟾胚胎静脉的血管生成性生长。
Development. 2000 Jan;127(2):269-78. doi: 10.1242/dev.127.2.269.

引用本文的文献

1
Ephs in cancer progression: complexity and context-dependent nature in signaling, angiogenesis and immunity.Eph 家族在癌症进展中的作用:信号转导、血管生成和免疫中的复杂性和上下文依赖性。
Cell Commun Signal. 2024 May 29;22(1):299. doi: 10.1186/s12964-024-01580-3.
2
Diverse roles for axon guidance pathways in adult tissue architecture and function.轴突导向通路在成体组织结构和功能中的多种作用。
Nat Sci (Weinh). 2022 Oct;2(4). doi: 10.1002/ntls.20220021. Epub 2022 Oct 2.
3
An investigation of binding interactions of tumor-targeted peptide conjugated polyphenols with the kinase domain of ephrin B4 and B2 receptors.
靶向肿瘤的肽共轭多酚与 Ephrin B4 和 B2 受体激酶结构域结合相互作用的研究。
Mol Divers. 2024 Apr;28(2):817-849. doi: 10.1007/s11030-023-10621-x. Epub 2023 Feb 27.
4
Evaluation of EphB4 as Target for Image-Guided Surgery of Breast Cancer.评估EphB4作为乳腺癌图像引导手术靶点的作用。
Pharmaceuticals (Basel). 2020 Jul 30;13(8):172. doi: 10.3390/ph13080172.
5
Ephrin‑B2 inhibits cell proliferation and motility in vitro and predicts longer metastasis‑free survival in breast cancer.Ephrin‑B2 在体外抑制细胞增殖和迁移,并预测乳腺癌无转移生存时间更长。
Int J Oncol. 2019 Dec;55(6):1275-1286. doi: 10.3892/ijo.2019.4892. Epub 2019 Oct 4.
6
Prognostic value of ephrin B receptors in breast cancer: An online survival analysis using the microarray data of 3,554 patients.Ephrin B受体在乳腺癌中的预后价值:使用3554例患者的微阵列数据进行的在线生存分析
Oncol Lett. 2019 Jul;18(1):742-750. doi: 10.3892/ol.2019.10363. Epub 2019 May 17.
7
Oestrogen receptor α AF-1 and AF-2 domains have cell population-specific functions in the mammary epithelium.雌激素受体 α 的 AF-1 和 AF-2 结构域在乳腺上皮细胞群体中具有特定的功能。
Nat Commun. 2018 Nov 9;9(1):4723. doi: 10.1038/s41467-018-07175-0.
8
Overexpression of erythropoietin-producing hepatocyte receptor B4 and ephrin-B2 is associated with estrogen receptor expression in endometrial adenocarcinoma.促红细胞生成素产生肝细胞受体B4和Ephrin-B2的过表达与子宫内膜腺癌中的雌激素受体表达相关。
Oncol Lett. 2017 Apr;13(4):2109-2114. doi: 10.3892/ol.2017.5698. Epub 2017 Feb 8.
9
Estrogen and testosterone in concert with EFNB3 regulate vascular smooth muscle cell contractility and blood pressure.雌激素和睾酮与EFNB3协同调节血管平滑肌细胞的收缩性和血压。
Am J Physiol Heart Circ Physiol. 2016 Apr 1;310(7):H861-72. doi: 10.1152/ajpheart.00873.2015. Epub 2016 Feb 5.
10
Anti-tumour effects of antibodies targeting the extracellular cysteine-rich region of the receptor tyrosine kinase EphB4.靶向受体酪氨酸激酶EphB4细胞外富含半胱氨酸区域的抗体的抗肿瘤作用
Oncotarget. 2015 Apr 10;6(10):7554-69. doi: 10.18632/oncotarget.3199.